채혈침 홀더 시장 : 시장 예측(2026-2032년)

The Blood Collection Needle Holder Market is projected to grow by USD 21.70 billion at a CAGR of 7.58% by 2032.

Blood Collection Needle Holders: Executive Overview

Blood collection needle holders are components used to connect blood-collection needles with evacuated tubes, syringes, or related sampling systems. Their importance is tied to specimen integrity, phlebotomist safety, workflow consistency, and compatibility with collection protocols. Demand conditions are shaped by routine diagnostics, hospital and outpatient sampling, occupational-safety requirements, infection-control practices, and procurement preferences for standardized or safety-engineered devices.

Safety, Standardization, and Workflow Reshape the Landscape

The landscape is shifting toward devices that reduce needlestick exposure, support one-handed handling, and integrate reliably with established blood-collection procedures. Buyers increasingly assess clear activation feedback, secure needle attachment, ergonomic grip, disposal compatibility, and consistency across different tube formats. Standardization is also becoming more important as healthcare networks consolidate purchasing and seek to simplify training, inventory management, and quality assurance across facilities.

Artificial Intelligence Strengthens Quality and Operational Decisions

Artificial intelligence is most relevant as an enabling layer around blood-collection workflows rather than as a replacement for the holder itself. AI-supported systems can help identify collection errors, detect unusual rejection patterns, optimize inventory replenishment, and analyze incident reports. When linked with laboratory and supply-chain data, these tools may improve traceability and highlight training needs. Their practical value depends on data quality, interoperability, cybersecurity, and appropriate human oversight.

Regional Priorities Differ Across North America, Latin America, Europe, Middle East, Africa, and Asia-Pacific

North America generally emphasizes occupational safety, regulatory compliance, and system-wide procurement consistency. Europe places strong weight on worker protection, sustainability, and harmonized clinical procedures. Asia-Pacific combines advanced hospital systems with rapidly expanding diagnostic capacity, creating varied requirements for compatibility, affordability, and local distribution. Latin America often balances safety improvements with budget discipline and supply continuity. The Middle East is influenced by centralized healthcare investment, imported-device dependence, and demand for reliable hospital infrastructure. Africa presents a broad mix of public, private, and donor-supported care settings, where durability, training, availability, and cost control are especially important.

ASEAN, BRICS, EU, G7, GCC, and NATO Highlight Different Procurement Conditions

ASEAN markets reflect diverse regulatory systems and healthcare-development levels, making adaptable distribution and training important. BRICS economies combine significant domestic healthcare needs with varied manufacturing, reimbursement, and procurement environments. The European Union favors regulatory alignment and cross-border quality expectations. G7 countries typically prioritize mature safety standards, evidence-based procurement, and workflow integration. GCC members often benefit from concentrated healthcare purchasing and modern facility development, while NATO-aligned systems may place added emphasis on resilient supply chains, emergency preparedness, and interoperability across clinical settings.

Country-Level Variation Shapes Product Fit and Route to Market

Australia and Canada emphasize safety, consistent clinical practice, and dependable supply across geographically dispersed systems. Brazil, Mexico, India, China, and Russia present varied combinations of public procurement, domestic production, regional distribution, and price sensitivity. France, Germany, Italy, Spain, and the United Kingdom operate within mature European or European-influenced quality and regulatory environments, with attention to sustainability and standardized practice. Japan and South Korea place strong emphasis on precision, reliability, and advanced healthcare operations. The United States remains highly attentive to needlestick prevention, institutional protocols, and product compatibility across complex provider networks.

Prioritize Verified Safety, Compatibility, and Supply Resilience

Industry leaders should prioritize holders with clear safety activation, ergonomic usability, secure connections, and compatibility with the collection systems used by target facilities. Evidence should be generated through usability testing, incident monitoring, and documented quality controls rather than promotional claims alone. Suppliers should segment offerings by regulatory environment and care setting, while maintaining transparent labeling and training materials. Resilient sourcing, dual-qualified components, regional inventory planning, and digital traceability can reduce disruption. AI investments should focus first on measurable workflow problems, with governance controls for privacy, validation, and human review.

Methodology Combines Structured Market Framing With Evidence-Based Interpretation

This executive summary uses the defined product category and required geographic groupings as the analytical scope. Insights are organized through a qualitative review framework covering clinical use, occupational safety, procurement behavior, regulatory considerations, workflow integration, supply resilience, and technology adoption. Regional, group, and country observations are interpreted comparatively rather than quantified. No market estimates, shares, forecasts, or company-specific claims are used; conclusions should be validated against current regulatory documents, clinical guidance, procurement records, and facility-level usage data before implementation.

Reliable Needle Holders Support Safer, More Consistent Blood Collection

The category is being shaped by the combined priorities of worker safety, specimen quality, operational simplicity, regulatory alignment, and dependable availability. Although requirements differ across regions, economic groupings, and countries, buyers consistently benefit from products that are easy to use, compatible with existing systems, and supported by credible quality evidence. Leaders that connect product design with training, traceability, resilient supply, and carefully governed digital tools will be better positioned to address evolving blood-collection needs.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. New Revenue Opportunities
• 3.4. Next-Generation Business Models
• 3.5. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Blood Collection Needle Holder Market, by Type

• 7.1. Introduction
• 7.2. Auto Disable Holders
• 7.3. Safety Needle Holders
  • 7.3.1. Automatic Safety Needle Holders
  • 7.3.2. Manual Safety Needle Holders
• 7.4. Syringe Holders
  • 7.4.1. Reusable Syringe Holders
  • 7.4.2. Single Use Syringe Holders
• 7.5. Vacuum Tube Holders
  • 7.5.1. Conventional Vacuum Tube Holders
  • 7.5.2. Safety Vacuum Tube Holders
    • 7.5.2.1. Active Safety Vacuum Tube Holders
    • 7.5.2.2. Passive Safety Vacuum Tube Holders

8. Blood Collection Needle Holder Market, by Material

• 8.1. Introduction
• 8.2. Aluminum
• 8.3. Plastic
• 8.4. Stainless Steel

9. Blood Collection Needle Holder Market, by End User

• 9.1. Introduction
• 9.2. Ambulatory Care Centers
• 9.3. Diagnostic Laboratories
• 9.4. Hospitals

10. Blood Collection Needle Holder Market, by Distribution Channel

• 10.1. Introduction
• 10.2. Hospital Purchases
• 10.3. Medical Distributors
• 10.4. Online Stores
• 10.5. Retail Pharmacies

11. Blood Collection Needle Holder Market, by Region

• 11.1. Introduction
• 11.2. Asia-Pacific
• 11.3. North America
• 11.4. Latin America
• 11.5. Europe
• 11.6. Middle East
• 11.7. Africa

12. Blood Collection Needle Holder Market, by Group

• 12.1. Introduction
• 12.2. ASEAN
• 12.3. GCC
• 12.4. European Union
• 12.5. BRICS
• 12.6. G7
• 12.7. NATO

13. Blood Collection Needle Holder Market, by Country

• 13.1. Introduction
• 13.2. United States
• 13.3. Canada
• 13.4. Mexico
• 13.5. Brazil
• 13.6. United Kingdom
• 13.7. Germany
• 13.8. France
• 13.9. Russia
• 13.10. Italy
• 13.11. Spain
• 13.12. China
• 13.13. India
• 13.14. Japan
• 13.15. Australia
• 13.16. South Korea

14. Competitive Landscape

• 14.1. Market Share Analysis, 2025
• 14.2. Market Concentration Analysis, 2025
  • 14.2.1. Concentration Ratio (CR)
  • 14.2.2. Herfindahl Hirschman Index (HHI)
• 14.3. Recent Developments & Impact Analysis, 2025
• 14.4. Product Portfolio Analysis, 2025
• 14.5. Benchmarking Analysis, 2025

15. Company Profiles

• 15.1. Becton, Dickinson and Company
• 15.2. China Weigao Group Medical Polymer Co., Ltd.
• 15.3. Greiner Bio-One International GmbH
• 15.4. Hindustan Syringes & Medical Devices Limited
• 15.5. Jiangsu Jichuan Medical Instruments Co., Ltd.
• 15.6. Nipro Corporation
• 15.7. Polymedicure Ltd.
• 15.8. Sarstedt AG & Co. KG
• 15.9. Shandong Molong Medical Device Co., Ltd.
• 15.10. Terumo Corporation
• 15.11. Unimed S.r.l.

16. Key Experts